Pan, Yu-Chen Jia, Zhi-Fang Wang, Yue-Qi Yang, Na Liu, Jian-Xun Zhai, Xiang-Jun Song, Ying Wang, Chong Li, Jie Jiang, Jing
...
Published in
Journal of viral hepatitis
The study aimed to assess whether caesarean section and nonbreastfeeding can prevent mother-to-child transmission (MTCT) in HBsAg- and HBeAg-positive mothers via a cohort study and a meta-analysis. (1) Pregnant women who were positive for HBsAg and HBeAg and did not receive antiviral treatment during pregnancy were recruited from the First Hospital...
Van Nuil, Jennifer Ilo Umutesi, Grace Shumbusho, Fabienne Kateera, Frederick Dushimimana, Jean de Dieu Muvunyi, Claude Mambo Musabeyezu, Emmanuel Mukabatsinda, Constance Ntirenganya, Cyprien Kabahizi, Jules
...
Published in
Journal of viral hepatitis
Around 71 million people are living with chronic hepatitis C virus (HCV) infection, with approximately 14% residing in sub-Saharan Africa. Direct-acting antiviral (DAA) therapies offer clear benefits for liver-related morbidity and mortality, and data from high-income settings suggest that DAA treatments also provide significant benefits in terms o...
Pflüger, Lisa Sophie Schulze Zur Wiesch, Julian Polywka, Susanne Lütgehetmann, Marc
Published in
Journal of viral hepatitis
In vitro cell culture experiments and animal models have demonstrated that hepatitis delta virus (HDV) can theoretically propagate being enveloped by human pathogenic viruses other than hepatitis B virus (HBV), namely hepatitis C virus (HCV) and dengue virus. However, the clinical relevance of these findings and whether HDV replication occurs in re...
Phillips, Clare O'Sullivan, Margaret Schulkind, Jasmine Jones, Christina J Verma, Sumita
Published in
Journal of viral hepatitis
Sung, Julie C Wyatt, Brooke Perumalswami, Ponni V Branch, Andrea
Published in
Journal of viral hepatitis
Thank you for the opportunity to respond to the important suggestion made by Drs. Weiwei Ye and Xiaofei Li regarding our study, "Hepatitis C Cure Improved Patient-reported Outcomes in Patients with and without Liver Fibrosis in a Prospective Study at a Large Urban Medical Center." Because we calculated and analyzed the SF-36 vitality score for five...
Jack, Kathryn Linsley, Paul Thomson, Brian James Irving, William Lucien
Published in
Journal of viral hepatitis
The prison population is central to the campaign to eliminate hepatitis C virus as a public health threat. In the UK, this has led to the introduction of a national 'opt-out' policy, requiring people in prison to be tested for HCV unless they decline, with a target to test 75% of those admitted. However, in a representative prison estate in the Eas...
Carrat, Fabrice Nahon, Pierre Fontaine, Hélène Pol, Stanislas Hejblum, Gilles
Published in
Journal of viral hepatitis
Comparisons of time-to-event clinical outcomes between patients with or without a sustained virological response (SVR) after treatment of chronic hepatitis C infection have been repeatedly reported in emphasizing the potential clinical impact of treatment. Combining recently published data from different therapeutic eras with simple examples, we sh...
Nangia, Gayatri Borges, Kelly Reddy, K Rajender
Published in
Journal of viral hepatitis
Due to the unfortunate epidemic of opioid overdose deaths among people who inject drugs (PWID) in North America, there has been an increase in the availability of hepatitis C (HCV)-positive organs for transplantation and consequently the potential to decrease waiting times for solid organ transplantation if an HCV-uninfected recipient is willing to...
Maisa, Anna Semple, Susan Griffiths, Alison Ngui, Siew Lin Verlander, Neville Q McCaughey, Conall Doherty, Lorraine Jessop, Lucy
Published in
Journal of viral hepatitis
From July to August 2016, 4 homeless people who injected drugs (PWID) with acute or recent hepatitis C virus (HCV) infection were reported in Belfast. A multidisciplinary team including public health, homeless and addiction services undertook an investigation to identify risk behaviours and interrupt transmission chains. Recent HCV cases were defin...
Usman, Zainab Mijočević, Hrvoje Karimzadeh, Hadi Däumer, Martin Al-Mathab, Mamun Bazinet, Michel Frishman, Dmitrij Vaillant, Andrew Roggendorf, Michael
Published in
Journal of viral hepatitis
Chronic HBV infection results in various clinical manifestations due to different levels of immune response. In recent years, hepatitis B treatment has improved by long-term administration of nucleos(t)ide analogues (NUCs) and peg-interferon. Nucleic acid polymers (NAPs; REP 2139-Ca and REP 2139-Mg) are new antiviral drugs that block the assembly o...
